Cooper Cos Aktie News

Cooper's Lack of Strategic Focus, Misaligned Incentives, and Inadequate Board Oversight Have Led to Meaningful Underperformance

Jana announced a top portfolio position in Cooper and plans to push for strategic alternatives, including a potential combination for its contact lens unit.

SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The hedge fund will push Cooper to improve how it allocates capital in order to boost returns, the WSJ said.

Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.

Cooper Companies may strongly outperform the S&P 500 going forward, especially in a recessionary environment, rebounding from 2025's sell-off. COO trades at decade-low enterprise valuations, with renewed insider buying, positive trading momentum, and a history of resilience during economic downturns. The company leads the global contact lens market, maintains a solid balance sheet, and just exp...

SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company's share repurchase program. The share repurchase program now totals $2 billion.

The Cooper Companies, Inc. (NASDAQ:COO ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 3:00 PM EDT Company Participants Albert White - President, CEO & Non-Independent Director Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst All right. Welcome back.